Abstract: Disclosed are a method for determining a platelet concentration of a blood sample, a hematology system and a storage medium.

Abstract: The present disclosure relates to a composite logic gate circuit, including: a simple logic gate circuit including a first logic gate circuit and an inverter circuit, a first PMOS transistor, and a first NMOS transistor. The first logic gate circuit is configured to receive a first input signal and a second input signal, and to output a first output signal. The inverter circuit includes a second PMOS transistor and a second NMOS transistor. A source of the second PMOS transistor is coupled to a power input terminal, a drain is coupled to a drain of the second NMOS transistor, and a gate is configured to receive the first output signal. A source of the second NMOS transistor is coupled to a ground terminal, and a gate is configured to receive the first output signal. A source of the first PMOS transistor is coupled to the drain of the second PMOS transistor, a drain is coupled to a drain of the first NMOS transistor, and a gate is configured to receive a third input signal.

Abstract: A display substrate and a display device are provided. The display substrate includes a base substrate, at least one group of contact pads, a plurality of first light-emitting elements, a plurality of first pixel driving circuits, a plurality of connecting traces, a plurality of data lines and a plurality of leads. The display area includes a first display area and a second display area; the first light-emitting elements are located in the first display area; the first pixel driving circuits are located in the second display area; the leads are located in the first display area and the peripheral area, and connect the data lines and the at least one group of contact pads; orthographic projections of the first light-emitting elements on a substrate surface of the base substrate are at least partly overlapped with orthographic projections of the leads on the substrate surface of the base substrate.

Abstract: A method for installing a maximum power point tracking (MPPT) controller is provided. The method includes acquiring an occlusion area proportion of a photovoltaic string in a photovoltaic system, optimizing the occlusion area proportion to generate a target occlusion area proportion, determining a target position from the photovoltaic string according to the target occlusion area proportion, and installing the MPPT controller at the target position.

Abstract: The present disclosure discloses a sludge composite conditioner based on iron-containing sludge pyrolysis residue as well as a preparation method and use thereof. The sludge composite conditioner comprises iron-containing sludge pyrolysis residue and an oxidant used in combination with the iron-containing sludge pyrolysis residue, in which the iron-containing sludge pyrolysis residue is pyrolysis residue obtained by dewatering iron-containing sludge to obtain an iron-containing sludge cake and then pyrolyzing the iron-containing sludge cake, the iron-containing sludge being obtained from an advanced oxidation technology involving an iron-containing reagent.

Abstract: Disclosed herein are pharmaceutical formulations including epinephrine that have increased epinephrine retention over long-term storage, e.g., 30-months. In one aspect, a formulation includes: one or more of 0.1 mg/mL of epinephrine or a pharmaceutically acceptable salt thereof provided without any overage, a tonicity regulating agent including 8.2 mg/mL of sodium chloride, a pH adjusting agent including a mixture of 1.5 mg/mL sodium citrate dihydrate, 3.3 mg/mL of citric acid monohydrate, and, optionally, an as-needed amount of sodium hydroxide to maintain the pH level of the formulation within a range of 3.6 to 4.0, 0.075 mg/mL of sodium metabisulfite, and 4 ?g/mL of ethylene diamine tetra-acetate disodium. The formulation has an API recovery of 94.5% or more after at least 30 months of storage at long-term storage conditions defined as 25° C.±2° C. at 1 atmosphere. In addition, in another aspect, a formulation includes 1 mg/mL of epinephrine and other ingredients.

Abstract: Disclosed herein are pharmaceutical formulations including epinephrine that have increased epinephrine retention over long-term storage, e.g., 30-months. In one aspect, a formulation includes: one or more of 0.1 mg/mL of epinephrine or a pharmaceutically acceptable salt thereof provided without any overage, a tonicity regulating agent including 8.2 mg/mL of sodium chloride, a pH adjusting agent including a mixture of 1.5 mg/mL sodium citrate dihydrate, 3.3 mg/mL of citric acid monohydrate, and, optionally, an as-needed amount of sodium hydroxide to maintain the pH level of the formulation within a range of 3.6 to 4.0, 0.075 mg/mL of sodium metabisulfite, and 4 ?g/mL of ethylene diamine tetra-acetate disodium. The formulation has an API recovery of 94.5% or more after at least 30 months of storage at long-term storage conditions defined as 25° C.±2° C. at 1 atmosphere. In addition, in another aspect, a formulation includes 1 mg/mL of epinephrine and other ingredients.

Abstract: Disclosed herein are pharmaceutical formulations including epinephrine that have increased epinephrine retention over long-term storage, e.g., 30-months. In one aspect, a formulation includes: one or more of 0.1 mg/mL of epinephrine or a pharmaceutically acceptable salt thereof provided without any overage, a tonicity regulating agent including 8.2 mg/mL of sodium chloride, a pH adjusting agent including a mixture of 1.5 mg/mL sodium citrate dihydrate, 3.3 mg/mL of citric acid monohydrate, and, optionally, an as-needed amount of sodium hydroxide to maintain the pH level of the formulation within a range of 3.6 to 4.0, 0.075 mg/mL of sodium metabisulfite, and 4 ?g/mL of ethylene diamine tetra-acetate disodium. The formulation has an API recovery of 94.5% or more after at least 30 months of storage at long-term storage conditions defined as 25° C.±2° C. at 1 atmosphere. In addition, in another aspect, a formulation includes 1 mg/mL of epinephrine and other ingredients.

Abstract: Provided herein are protein translation inhibitors and pharmaceutical compositions thereof that bind to an RNA Recognition motif in heterogeneous ribonucleoprotein A18 to inhibit binding to mRNA transcripts thereby inhibiting protein synthesis. Also provided is a method for treating a cancer by administering a pharmaceutically acceptable amounts of at least one of the protein translation inhibitors.

Abstract: A method of detecting brake fade for a vehicle brake system having wheel brakes susceptible to brake fade, includes the steps of: (a) providing a brake system including wheel brakes; and (b) determining the presence of brake fade within the vehicle system utilizing adaptive references maps, and wherein the adaptive reference maps include storing vehicle deceleration data and brake system fluid volume at different pressure points in a histogram.

Abstract: A method is provided for controlling regenerative braking for a vehicle having a propulsion system, a motor, a transmission, and a clutch selectively coupling the motor to the transmission. The method includes estimating a future time at which the clutch disengages from the transmission. A rotational speed at which the clutch disengages from the transmission is calculated based on an idle speed of the propulsion system. A difference between a speed of the motor and the clutch disengage speed is monitored. A ramp down of regenerative torque on the motor is initiated when the difference is below a predetermined value and before the future clutch disengage time elapses.

Abstract: A method of controlling the fluid pressure at wheel brakes of a brake system, the method comprising: (a) providing a brake system capable of delivering fluid pressure to the wheel brakes during an autonomous braking event, and wherein the brake system includes a brake pedal and sensor for sensing a driver's braking intent when applying force to the brake pedal; (b) controlling the fluid pressure at the wheel brakes at a predetermined pressure during an autonomous braking event, wherein the sensor detects no depression of the brake pedal; (c) cancelling the autonomous braking event when the sensor detects depression of the brake pedal; and (d) subsequently to step (c), the brake system enters into a handoff procedure to maintain the predetermined pressure at the wheel brakes after the sensor senses the brake pedal being depressed when a requested pressure by the driver is less than the predetermined pressure.

Abstract: Provided herein are protein translation inhibitors and pharmaceutical compositions thereof that bind to an RNA Recognition motif in heterogeneous ribonucleoprotein A18 to inhibit binding to mRNA transcripts thereby inhibiting protein synthesis. Also provided is a method for treating a cancer by administering a pharmaceutically acceptable amounts of at least one of the protein translation inhibitors.

Abstract: Live presentation sessions are carried out by broadcasting non-image events of a presenter, which non-image events are subsequently performed over instances of shared content that are stored at user devices of a set of audience members. A live presentation can be initiated when two or more users that are authorized to access a content object stored in a shared content repository are authenticated. The presentation session proceeds with delivery of individual instances of the content object to each of the user devices corresponding to a presenter's user device and an audience member's user device. Upon detection of presentation actions that occur over one of the instances of the content object, the presentation actions are codified into a non-image event object, which is then sent to the audience member's user device. Continuing presentation actions are carried-out over respective instances of the content object at the user device of the audience member.

Abstract: A method of controlling the fluid pressure at wheel brakes of a brake system, the method comprising: (a) providing a brake system capable of delivering fluid pressure to the wheel brakes during an autonomous braking event, and wherein the brake system includes a brake pedal and sensor for sensing a driver's braking intent when applying force to the brake pedal; (b) controlling the fluid pressure at the wheel brakes at a predetermined pressure during an autonomous braking event, wherein the sensor detects no depression of the brake pedal; (c) cancelling the autonomous braking event when the sensor detects depression of the brake pedal; and (d) subsequently to step (c), the brake system enters into a handoff procedure to maintain the predetermined pressure at the wheel brakes after the sensor senses the brake pedal being depressed when a requested pressure by the driver is less than the predetermined pressure.

Abstract: A method of detecting brake fade for a vehicle brake system having wheel brakes susceptible to brake fade, includes the steps of: (a) providing a brake system including wheel brakes; and (b) determining the presence of brake fade within the vehicle system utilizing adaptive references maps, and wherein the adaptive reference maps include storing vehicle deceleration data and brake system fluid volume at different pressure points in a histogram.

Abstract: The present disclosure discloses a sludge composite conditioner based on iron-containing sludge pyrolysis residue as well as a preparation method and use thereof. The sludge composite conditioner comprises iron-containing sludge pyrolysis residue and an oxidant used in combination with the iron-containing sludge pyrolysis residue, in which the iron-containing sludge pyrolysis residue is pyrolysis residue obtained by dewatering iron-containing sludge to obtain an iron-containing sludge cake and then pyrolyzing the iron-containing sludge cake, the iron-containing sludge being obtained from an advanced oxidation technology involving an iron-containing reagent.

Abstract: The present invention discloses a dosage optimization method of a chemical conditioner for deeply dewatering the sludge in a municipal wastewater treatment plant, comprises the following steps: (1) optimizing a dosage of a chemical conditioner added into a specific sludge to obtain an optimal dosage proportion of the chemical conditioner corresponding to unit mass of organic matter; (2) calculating an optimal dosage of the chemical conditioner applicable for other sludge to be treated; and (3) adding the chemical conditioner into the sludge to be treated for sludge conditioning treatment, and then performing mechanical dewatering treatment, so as to obtain a deeply dewatered sludge with a moisture content of less than 60%. By improving the reference basis as the key chemical conditioner dosage, the method can effectively solve the problem that types and moisture content range of sludge to which the chemical conditioner dosage control method is applicable are narrow.

Abstract: Live presentation sessions are carried out by broadcasting non-image events of a presenter, which non-image events are subsequently performed over instances of shared content that are stored at user devices of a set of audience members. A live presentation can be initiated when two or more users that are authorized to access a content object stored in a shared content repository are authenticated. The presentation session proceeds with delivery of individual instances of the content object to each of the user devices corresponding to a presenter's user device and an audience member's user device. Upon detection of presentation actions that occur over one of the instances of the content object, the presentation actions are codified into a non-image event object, which is then sent to the audience member's user device. Continuing presentation actions are carried-out over respective instances of the content object at the user device of the audience member.

Abstract: A high-gradient internal-circulating oil-cooled Magnetic Separator, includes magnetic system coils, an internal-circulating oil path system, an external-cooling system and an oil conservator. The magnetic system coils are used for generating excitation magnetic field to achieve the iron-absorption function, the magnetic paths of the magnetic system coils being an open magnetic path structure. The internal-circulating oil path system is used for allocation and collection circulation of transformer oil. The external-cooling system is used for heat dissipation of transformer oil to achieve internal heat dissipation balance. The oil conservator is used as a supplementary container for the transformer oil expansion during the apparatus's operation. An internal-circulating structure is employed, and external-circulating pipes are simplified, circulating resistance in oil paths being reduced, problems including complex interference in oil paths arrangement, low circulation efficiency, leakage at welding spots, etc.